Salesforce Inc. (CRM)
This Is Not The Time To Give Up On Salesforce
Salesforce continues to deliver strong results, highlighted by resilient revenue growth and a committed share repurchase program. The Informatica acquisition is attractively valued, contrasting with past expensive deals, and should create substantial shareholder value through cross-selling opportunities. Management remains committed to profitability and shareholder returns, with a strong balance sheet and hints of sustained growth.
CRM vs. NOW: Which Workflow Automation Stock Has More Upside?
ServiceNow NOW and Salesforce CRM are leading workflow automation platforms, helping enterprises streamline operations through cloud-based software and AI-powered tools. Platforms provided by these companies are widely used by large enterprises to drive efficiency and improve service delivery.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Salesforce.com (CRM) Declines More Than Market: Some Information for Investors
The latest trading day saw Salesforce.com (CRM) settling at $267.39, representing a -1.06% change from its previous close.
Salesforce Inc. (NYSE: CRM) Price Prediction and Forecast 2025-2030 (July 2025)
Shares of Salesforce Inc. ( NYSE: CRM ) lost 1.58% over the past month, dragging down the stock's year-to-date loss to 18.61%.
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
Salesforce.com (CRM) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Salesforce.com (CRM) closed at $267.22, indicating a +1.38% shift from the previous trading day.
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.
Salesforce vs. HubSpot: Which CRM Stock Is the Smarter Buy Now?
HUBS outpaces CRM in sales growth and market momentum, making it a better investment pick despite the premium.
Why Salesforce.com (CRM) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce: Undervalued And Ready To Rebound On A Likely Q2 Beat
After a prolonged correction, Salesforce is oversold. I think its AI growth engine, combining Agentforce and Data Cloud, is poised to re-accelerate top-line growth. I anticipate strong Q2 FY2026 results, driven by resilient demand and the successful integration of recent acquisitions. Wall Street has set a low bar for Q2 earnings, with consensus estimates below management's own guidance, creating a clear setup for a beat.
